EPIPHASIC - Trademark Details
Status: 700 - Registered
Image for trademark with serial number 86030165
Serial Number
86030165
Registration Number
4760880
Word Mark
EPIPHASIC
Status
700 - Registered
Status Date
2015-06-23
Filing Date
2013-08-06
Registration Number
4760880
Registration Date
2015-06-23
Mark Drawing
4000 - Standard character mark Typeset
Published for Opposition Date
2014-08-05
Attorney Name
Keith R. Lange
Law Office Assigned Location Code
M80
Employee Name
YOUNG, CARRIE SKYE
Statements
Goods and Services
A proprietary dermatological delivery system in the form of pharmaceutical preparations, namely, drug delivery agents consisting of compounds that facilitate the topical and transdermal delivery of a wide range of pharmaceuticals
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2013-08-14
Primary Code
005
First Use Anywhere Date
2015-03-04
First Use In Commerce Date
2015-03-04
Current Trademark Owners
Party Name
Avidas Pharmaceuticals LLC
Party Type
30 - Original Registrant
Legal Entity Type
16 - Limited Liability Company
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Avidas Pharmaceuticals LLC
Party Type
30 - Original Registrant
Legal Entity Type
16 - Limited Liability Company
Address
Please log in with your Justia account to see this address.
Party Name
Avidas Pharmaceuticals LLC
Party Type
20 - Owner at Publication
Legal Entity Type
16 - Limited Liability Company
Address
Please log in with your Justia account to see this address.
Party Name
Avidas Pharmaceuticals LLC
Party Type
10 - Original Applicant
Legal Entity Type
16 - Limited Liability Company
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Keith R. Lange
Address
Please log in with your Justia account to see this address.
Trademark Events
Event DateEvent Description
2013-08-09NEW APPLICATION ENTERED IN TRAM
2013-08-14NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2013-09-28ASSIGNED TO EXAMINER
2013-09-28NON-FINAL ACTION WRITTEN
2013-09-28NON-FINAL ACTION E-MAILED
2013-09-28NOTIFICATION OF NON-FINAL ACTION E-MAILED
2013-10-29EXAMINERS AMENDMENT -WRITTEN
2013-10-29EXAMINERS AMENDMENT E-MAILED
2013-10-29NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
2013-10-29EXAMINER'S AMENDMENT ENTERED
2013-10-29APPROVED FOR PUB - PRINCIPAL REGISTER
2013-11-19ASSIGNED TO LIE
2013-11-19LAW OFFICE PUBLICATION REVIEW COMPLETED
2013-12-01WITHDRAWN FROM PUB - OG REVIEW QUERY
2013-12-16PREVIOUS ALLOWANCE COUNT WITHDRAWN
2013-12-28PRIORITY ACTION WRITTEN
2013-12-28PRIORITY ACTION E-MAILED
2013-12-28NOTIFICATION OF PRIORITY ACTION E-MAILED
2014-06-27TEAS RESPONSE TO OFFICE ACTION RECEIVED
2014-06-27CORRESPONDENCE RECEIVED IN LAW OFFICE
2014-06-28TEAS/EMAIL CORRESPONDENCE ENTERED
2014-06-28APPROVED FOR PUB - PRINCIPAL REGISTER
2014-06-30LAW OFFICE PUBLICATION REVIEW COMPLETED
2014-07-16NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2014-08-05PUBLISHED FOR OPPOSITION
2014-08-05OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2014-09-30NOA E-MAILED - SOU REQUIRED FROM APPLICANT
2015-03-29TEAS STATEMENT OF USE RECEIVED
2015-05-02CASE ASSIGNED TO INTENT TO USE PARALEGAL
2015-03-29USE AMENDMENT FILED
2015-05-02STATEMENT OF USE PROCESSING COMPLETE
2015-05-16ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
2015-05-19NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
2015-06-23REGISTERED-PRINCIPAL REGISTER
2020-06-23COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
2021-12-21TEAS SECTION 8 & 15 RECEIVED